Dow Corning Asks Judge To Rule Against Breast Implant Plan Modification
This article was originally published in The Gray Sheet
Executive Summary
Payments to the 94% of silicone breast implant claimants who agreed to the Dow Corning Joint Plan of Reorganization should begin soon provided a recent decision by the U.S. Bankruptcy Court to modify the plan is retained.
You may also be interested in...
Breast Implant Litigation
Proponents of the Dow Corning Joint Plan of Reorganization will present evidence at a June 28 confirmation hearing in the U.S. Bankruptcy Court in Bay City, Michigan in an effort to obtain approval on the plan from the court. On June 1, the Tort Claimants Committee and Dow Corning announced acceptance of the settlement proposal. With more than 300,000 claimant votes submitted on various claim categories, 94% voted in favor of the plan. Court confirmation would allow claimants to select the settlement method for their claim and would resolve the company's Chapter 11 filing
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.